CFO’s First Insider Move Signals Confidence in OVID’s Trajectory and Future Growth Pulse
New CFO’s first insider purchase of 50,000 OVID shares signals confidence in the rare‑disorder pipeline and long‑term value. Read the full insights.
3 minutes to read
